
Makes learning interactive and engaging.
This comment is not public.
Todd Bull, MD, is Professor of Medicine in the Division of Pulmonary Sciences and Critical Care at the University of Colorado Anschutz Medical Campus. He serves as Director of the Center for Lungs and Breathing and Director of the Pulmonary Vascular Disease Center. Bull earned a BA from Northwestern University in 1990 and an MD from the University of Colorado Denver School of Medicine in 1994. He completed an internship at the University of Texas Southwestern Medical School Program in 1995, residency in Internal Medicine there in 1997, and fellowship in Pulmonary Disease and Critical Care Medicine at the University of Colorado University Hospital Program in 2001. After fellowship, Bull joined the University of Colorado faculty, dedicating his clinical efforts to patients with pulmonary vascular disease in outpatient clinics, inpatient wards, the cardiac catheterization laboratory, and medical intensive care unit.
Bull maintains an active research laboratory aimed at improving diagnosis and treatment of pulmonary hypertension. His investigations include pulmonary arterial hypertension, pulmonary embolism, pulmonary vascular disease, genomics of pulmonary arterial hypertension, and effects of viral infection on pulmonary hypertension. He participates in clinical trials of novel therapies for PAH and pulmonary embolism. Key publications include "Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results" (2024, European Respiratory Journal), "Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial" (2024, American Journal of Respiratory and Critical Care Medicine), "Right Ventricular Response to Acute Hypoxia among Healthy Humans" (2023, American Journal of Respiratory and Critical Care Medicine), "Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial" (2023, Circulation), and "Gene Microarray Analysis of Peripheral Blood Cells in Pulmonary Arterial Hypertension" (2004, American Journal of Respiratory and Critical Care Medicine). Bull has been recognized repeatedly as a Top Doctor in Denver by 5280 Magazine (2012-2020) in Pulmonary Medicine and Critical Care, Pulmonary Hypertension Physician of the Year by the Pulmonary Hypertension Association (2018), and Physician of the Year by the Colorado Society for Respiratory Care (2013). He is a member of the Clinical Excellence Society in the Department of Medicine.
